Purpose: this review aims to establish the easiest possible diagram to aid the ophthalmologist in the management of the numerous antiglaucomatous agents that have been increasing our therapeutic group.
Method: we have analyzed the indications, advantages and inconveniences of the medical treatment successively and have reviewed the criteria used to choose a specific drug based on glaucoma severity, general clinical history of the patient, tolerance, local and general adverse effects.
Results: finally, we have also considered the ease of compliance, validity of associations and influence of these factors in the patient's quality of life.
Conclusions: the final therapeutic outline is really an index that aims to facilitate a correct use standard.